Xeris Biopharma Holdings, Inc. XERS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s quick ratio?
- Xeris Biopharma Holdings, Inc. (XERS) reported quick ratio of 1.5× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s quick ratio changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s quick ratio increased by 28.4% year-over-year, from 1.2× to 1.5×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s quick ratio has grown at a -21.0% compound annual growth rate (CAGR), from 5.1× to 1.6×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.